このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Implementation, Safety, and Effectiveness of Outpatient Cardiac Telerehabilitation in Patients With Ischemic Heart Disease

2026年11月4日 更新者:Emilija Laurecke、Lithuanian University of Health Sciences

The goal of this prospective interventional study is to evaluate the effectiveness and safety of an outpatient cardiac telerehabilitation program during phase II rehabilitation in patients with ischemic heart disease. The main question is whether an outpatient cardiac telerehabilitation program during phase II rehabilitation is effective and safe for patients with ischemic heart disease.

Researchers will compare two groups:

  1. Control group - conventional outpatient cardiac rehabilitation at Kulautuva Rehabilitation Hospital.
  2. Intervention group - outpatient cardiac telerehabilitation delivered through a hybrid model, in which patient assessments, consultations, and other prescribed procedures are conducted at Kulautuva Rehabilitation Hospital, while patient education and exercise training programs are delivered remotely in an asynchronous manner. Smart wearable devices will monitor physiological parameters and physical activity, supporting individualized exercise recommendations.

During the study, researchers will collect and assess participants' medical history, existing risk factors, and current medications. Study participants will undergo the following tests:

  • Cardiopulmonary Exercise Testing (CPET);
  • Six-Minute Walk Test (6MWT);
  • International Physical Activity Questionnaire - Short Form (IPAQ-SF);
  • Fullerton Advanced Balance Scale (FAB);
  • Fagerström Test for Nicotine Dependence (FTND) (for participants who smoke);
  • Coronary Artery Disease Education Questionnaire - Short Version (CADE-Q SV);
  • Self-Care of Coronary Heart Disease Inventory (SC-CHDI V2.1);
  • Mediterranean Diet Adherence Screener (MEDAS);
  • Pittsburgh Sleep Quality Index (PSQI);
  • EuroQol Five-Dimension Questionnaire (EQ-5D);
  • System Usability Scale (SUS) (only for participants in the intervention group).

調査の概要

研究の種類

介入

入学 (推定)

100

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

      • Kulautuva、リトアニア
        • 募集
        • Kulautuva Rehabilitation Hospital
        • コンタクト:
        • 副調査官:
          • Egle Tamuleviciute-Prasciene
        • 副調査官:
          • Julija Borkyte-Sileikiene
        • 副調査官:
          • Raimondas Kubilius

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  1. Patients diagnosed with ischemic heart disease and referred to Phase II outpatient cardiac rehabilitation;
  2. Adults aged 18 years and older;
  3. Moderate to good functional exercise capacity, defined as a distance > 225 meters on the Six-Minute Walk Test at baseline;
  4. Willingness and ability to provide written informed consent to participate in the study.

Exclusion Criteria:

  1. Presence of implanted cardiac devices;
  2. Language barriers that may interfere with study participation;
  3. Cognitive impairment, defined as a Mini-Mental State Examination score < 25 points;
  4. Comorbidities that may significantly affect the participant's ability to perform physical exercises, mobility, or activities of daily living, including musculoskeletal disorders, neurological diseases, or other relevant medical conditions;
  5. Insufficient digital literacy or inability to use smart devices.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
アクティブコンパレータ:Conventional outpatient cardiac rehabilitation

Conventional outpatient cardiac rehabilitation at Kulautuva Rehabilitation Hospital

Participants receive comprehensive, individualized rehabilitation care tailored to their primary diagnosis and comorbidities. The rehabilitation program include: aerobic exercise on a cycle ergometer or treadmill (6 sessions/week), breathing exercises (6 sessions/week), strength and balance training (3 sessions/week), and aquatic exercise or Nordic walking, depending on the patient's clinical condition (2-3 sessions/week)

実験的:Cardiac Telerehabilitation

Cardiac telerehabilitation delivered through a hybrid model, in which patient assessments, consultations, and other prescribed procedures are conducted at Kulautuva Rehabilitation Hospital, while patient education and exercise training programs are delivered remotely in an asynchronous manner. Smart wearable devices will monitor physiological parameters and physical activity, supporting individualized exercise recommendations

Cardiac telerehabilitation is delivered through a hybrid model. In-person assessments, consultations, and other prescribed procedures are conducted at the Kulautuva Rehabilitation Hospital. At the same time, patients receive education and exercise training remotely at home using smart devices. Participants receive an individualized exercise program with exercise intensity tailored to their cardiovascular risk and physical capacity. Each participant is enrolled in the telemedicine platform, where a personalized home-based rehabilitation and health-monitoring plan is developed, including medication management, exercise training, and monitoring of relevant health parameters. Participants receive the necessary equipment. Additionally, participants in the intervention group receive a consultation with a physiotherapist about their home-based exercise program, along with training on proper use of wearable devices and mobile applications.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Cardiopulmonary Exercise Test
時間枠:From enrollment to the end of treatment at 3 weeks

This test will be performed to assess participants' cardiorespiratory fitness and exercise capacity. The test will be conducted using a cycle ergometer with respiratory gas analysis and electrocardiographic (ECG) monitoring. Exercise capacity will be assessed using an ergometer, starting at 25 W and increasing by 25 W every minute. Participants will be instructed to maintain a constant pedaling cadence of 50-60 revolutions per minute to ensure a stable workload. The progressive exercise duration is 8-12 minutes, depending on each participant's physical capacity and clinical condition, followed by a recovery period. During the test, blood pressure, heart rate, and ECG will be monitored, while oxygen uptake (VO₂), carbon dioxide production (VCO₂), minute ventilation (VE), maximal oxygen uptake (VO₂max), and ventilatory thresholds (VT1 and VT2) will be assessed. The heart rates corresponding to VT1 and VT2 will be identified and used to establish individualized aerobic exercise intensity

From enrollment to the end of treatment at 3 weeks
Six-Minute Walk Test
時間枠:From enrollment to the end of treatment at 3 weeks

This test assesses functional exercise capacity. Participants will be instructed to walk in an indoor corridor at a self-selected pace. Participants may slow down, stop, or rest as needed and resume walking when able. The total distance walked in six minutes (in meters) will be recorded as the primary outcome. Heart rate, blood pressure, and perceived exertion using the Borg scale will be assessed before and after the test.

From enrollment to the end of treatment at 3 weeks
International Physical Activity Questionnaire - Short Form
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, self-reported questionnaire evaluates physical activity in adults. The questionnaire consists of seven items assessing the frequency and duration of physical activity performed during the previous seven days, including walking, moderate-intensity physical activity, vigorous-intensity physical activity, and time spent sitting. The questionnaire score will be quantified in metabolic equivalents. Participants will be classified into three physical activity categories: low, moderate, or high.

From enrollment to the end of treatment at 3 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Fullerton Advanced Balance Scale
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, performance-based assessment evaluates static and dynamic balance. The test includes 10 tasks that assess different aspects of postural control, including standing with feet together and eyes closed, reaching forward, turning, stepping over obstacles, tandem walking, standing on one leg, and maintaining balance during other functional activities. Each task is scored on a five-point scale ranging from 0 (unable to perform the task) to 4 (optimal performance), resulting in a maximum total score of 40 points. Higher scores indicate better balance performance, while lower scores suggest greater balance impairment.

From enrollment to the end of treatment at 3 weeks
Fagerström Test
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, self-report questionnaire evaluates nicotine dependence. It includes six items assessing smoking behavior, such as the number of cigarettes smoked per day, time to the first cigarette after waking, difficulty refraining from smoking, and smoking patterns throughout the day. Each item is scored 0 to 10 points. Higher scores indicate greater nicotine dependence. Participants will be classified into five categories based on their total score: very low dependence (0-2 points), low dependence (3-4 points), moderate dependence (5 points), high dependence (6-7 points), and very high dependence (8-10 points).

From enrollment to the end of treatment at 3 weeks
Coronary Artery Disease Education Questionnaire - Short Version
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, self-reported questionnaire evaluates disease-related knowledge among patients participating in cardiac rehabilitation programs. The questionnaire consists of 20 items divided into five knowledge domains: medical condition, cardiovascular risk factors, exercise, nutrition, and psychosocial risk. Each domain includes four questions. Participants are required to select one of three response options: "True", "False", or "I don't know". Each correct answer is worth 1 point, while incorrect answers and "I don't know" responses are worth 0 points. The total score ranges from 0 to 20 points, with higher scores indicating greater knowledge of coronary artery disease and its management.

From enrollment to the end of treatment at 3 weeks
Self-Care of Coronary Heart Disease Inventory
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, self-report questionnaire assesses patients' ability to maintain health, manage disease-related symptoms, and engage in appropriate self-care behaviors. It comprises 22 items across three domains: self-care maintenance (10 items), self-care management (6 items), and self-care confidence (6 items). Each domain is scored separately, with scores standardized to a 0-100 scale. Higher scores indicate better self-care behaviors or greater confidence in self-care management.

From enrollment to the end of treatment at 3 weeks
Mediterranean Diet Adherence Screener
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, self-reported questionnaire evaluates dietary habits and adherence to the principles of the Mediterranean dietary pattern. The questionnaire includes 14 items that assess the frequency and quantity of key dietary components, including olive oil, vegetables, fruits, legumes, nuts, fish, meat, and other food products, as well as specific dietary habits. Each item is scored as either 0 or 1 point, depending on whether the participant meets the predefined dietary criterion. The total score ranges from 0 to 14 points, with higher scores indicating greater adherence to the Mediterranean diet. Participants will be categorized into three groups: low adherence (0-5 points), moderate adherence (6-9 points), and high adherence (10-14 points).

From enrollment to the end of treatment at 3 weeks
Pittsburgh Sleep Quality Index
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, self-report questionnaire assesses subjective sleep quality and sleep disturbances over the previous month. It comprises 19 items grouped into seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. A bed partner or roommate may complete additional questions, but these are not included in the overall score. Each component is scored 0 to 3 points, resulting in a total score of 0 to 21 points. Higher scores indicate poorer sleep quality; a total score greater than 5 points indicates poor sleep quality.

From enrollment to the end of treatment at 3 weeks
EuroQol Five-Dimension Five-Level Questionnaire
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, self-reported instrument evaluates participants' perceived health status and quality of life. The questionnaire assesses five health dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension uses five response levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. Higher questionnaire index values generally indicate better health-related quality of life.

From enrollment to the end of treatment at 3 weeks
System Usability Scale
時間枠:From enrollment to the end of treatment at 3 weeks

This standardized, self-reported questionnaire assesses participants' perceptions of system usability, ease of use, and overall user experience. The questionnaire consists of 10 statements ranging from 1 (strongly disagree) to 5 (strongly agree). The total scale score ranges from 0 to 100 points, with higher scores indicating better perceived usability. Usability is classified as excellent (>80.3 points), good (68-80.3 points), poor (51-<68 points), or very poor (<51 points).

From enrollment to the end of treatment at 3 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月1日

一次修了 (推定)

2030年11月1日

研究の完了 (推定)

2030年11月1日

試験登録日

最初に提出

2026年11月4日

QC基準を満たした最初の提出物

2026年11月4日

最初の投稿 (実際)

2026年11月10日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月10日

QC基準を満たした最後の更新が送信されました

2026年11月4日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

Individual participant data will not be shared to protect participant privacy and ensure the confidentiality of sensitive health information. However, the study results will be shared through scientific publications.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する